Found: 7
Select item for more details and to access through your institution.
Applying ASCO GU 2024 Data to Clinical Practice in Bladder, RCC Care.
- Published in:
- OncologyLive, 2024, v. 25, n. 8, p. 58
- By:
- Publication type:
- Article
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 392, doi. 10.1093/oncolo/oyad302
- By:
- Publication type:
- Article
Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5843, doi. 10.3390/cancers15245843
- By:
- Publication type:
- Article
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.621591
- By:
- Publication type:
- Article
First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma—A Retrospective Study.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00701
- By:
- Publication type:
- Article
Marked responses to pemetrexed chemotherapy for metastatic adenocarcinoma of the parotid gland: Case series.
- Published in:
- Head & Neck, 2019, v. 41, n. 6, p. E99, doi. 10.1002/hed.25658
- By:
- Publication type:
- Article
Supplements to Help Prevent Neuropathy During Chemotherapy? A Cautionary Tale.
- Published in:
- 2018
- By:
- Publication type:
- journal article